Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access: APRN
      • NetCE All Access: MD
      • NetCE All Access: PA
      • NetCE All Access: RN
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights: APRN
      • Prescriber Insights: MD
      • Prescriber Insights: PA
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Gastrointestinal Cancers
  5. Treatment

Treatment

  • Anemia (42)
  • Blood Products (4)
  • Breast Cancer (65)
  • Cancer (17)
  • Cervical Cancer (14)
  • Chemotherapy (6)
  • Chemotherapy-Induced Adverse Effects (35)
  • Colon Cancer (14)
  • Drugs/Products That May Increase Cancer Risk (85)
  • Gastrointestinal Cancers (24)
    • Prevention/Screening (23)
    • Treatment (4)
  • Hemophilia (2)
  • Hemorrhage (6)
  • Leukemia (1)
  • Lung Cancer (78)
  • Lymphoma & Multiple Myeloma (1)
  • Ovarian Cancer (1)
  • Prostate Cancer (17)
  • Renal Cancer (1)
  • Resources (56)
  • Sickle Cell Disease (4)
  • Skin Cancer (21)
1 - 4 of 4 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Algorithm: How to Manage High INRs in Warfarin Patients September 2020
Commentary: Managing Antithrombotics Before Minor Procedures May 2013
Other: Managing Antithrombotics Before Minor Procedures May 2013
Article: new oral cancer drugs, Nexavar and Sutent March 2006
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved